These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30567626)

  • 21. The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial.
    Juel CTB; Lund A; Andersen MM; Hansen CP; Storkholm JH; Rehfeld JF; van Hall G; Hartmann B; Wewer Albrechtsen NJ; Holst JJ; Vilsbøll T; Knop FK
    Diabetologia; 2020 Jul; 63(7):1285-1298. PubMed ID: 32394228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function.
    Kielgast U; Holst JJ; Madsbad S
    Diabetes; 2011 May; 60(5):1599-607. PubMed ID: 21441444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients.
    Samocha-Bonet D; Wong O; Synnott EL; Piyaratna N; Douglas A; Gribble FM; Holst JJ; Chisholm DJ; Greenfield JR
    J Nutr; 2011 Jul; 141(7):1233-8. PubMed ID: 21593352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
    Kuo P; Stevens JE; Russo A; Maddox A; Wishart JM; Jones KL; Greville H; Hetzel D; Chapman I; Horowitz M; Rayner CK
    J Clin Endocrinol Metab; 2011 May; 96(5):E851-5. PubMed ID: 21389144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of fat supplementation on postprandial GIP, GLP-1, ghrelin and IGFBP-1 levels: a pilot study on adolescents with type 1 diabetes.
    Lodefalk M; Carlsson-Skwirut C; Holst JJ; Aman J; Bang P
    Horm Res Paediatr; 2010; 73(5):355-62. PubMed ID: 20389106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia.
    Deane AM; Nguyen NQ; Stevens JE; Fraser RJ; Holloway RH; Besanko LK; Burgstad C; Jones KL; Chapman MJ; Rayner CK; Horowitz M
    J Clin Endocrinol Metab; 2010 Jan; 95(1):215-21. PubMed ID: 19892837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus.
    Schirra J; Leicht P; Hildebrand P; Beglinger C; Arnold R; Göke B; Katschinski M
    J Endocrinol; 1998 Jan; 156(1):177-86. PubMed ID: 9496247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
    Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
    Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans.
    Mandøe MJ; Hansen KB; Hartmann B; Rehfeld JF; Holst JJ; Hansen HS
    Am J Clin Nutr; 2015 Sep; 102(3):548-55. PubMed ID: 26178726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
    Meier JJ; Kemmeries G; Holst JJ; Nauck MA
    Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
    Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Butter differs from olive oil and sunflower oil in its effects on postprandial lipemia and triacylglycerol-rich lipoproteins after single mixed meals in healthy young men.
    Mekki N; Charbonnier M; Borel P; Leonardi J; Juhel C; Portugal H; Lairon D
    J Nutr; 2002 Dec; 132(12):3642-9. PubMed ID: 12468601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Dietary Fat and Protein on Glucoregulatory Hormones in Adolescents and Young Adults With Type 1 Diabetes.
    Harray AJ; Binkowski S; Keating BL; Horowitz M; Standfield S; Smith G; Paramalingam N; Jones T; King BR; Smart CEM; Davis EA
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e205-e213. PubMed ID: 34410410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monosodium glutamate stimulates secretion of glucagon-like peptide-1 and reduces postprandial glucose after a lipid-containing meal.
    Hosaka H; Kusano M; Zai H; Kawada A; Kuribayashi S; Shimoyama Y; Nagoshi A; Maeda M; Kawamura O; Mori M
    Aliment Pharmacol Ther; 2012 Nov; 36(9):895-903. PubMed ID: 22978669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial.
    Thazhath SS; Wu T; Bound MJ; Checklin HL; Standfield S; Jones KL; Horowitz M; Rayner CK
    Am J Clin Nutr; 2016 Jan; 103(1):66-70. PubMed ID: 26607942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprandial glucose, insulin, and incretin responses to grain products in healthy subjects.
    Juntunen KS; Niskanen LK; Liukkonen KH; Poutanen KS; Holst JJ; Mykkänen HM
    Am J Clin Nutr; 2002 Feb; 75(2):254-62. PubMed ID: 11815315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Title: Differentiating the effects of whey protein and guar gum preloads on postprandial glycemia in type 2 diabetes.
    Watson LE; Phillips LK; Wu T; Bound MJ; Checklin H; Grivell J; Jones KL; Horowitz M; Rayner CK
    Clin Nutr; 2019 Dec; 38(6):2827-2832. PubMed ID: 30583967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes.
    Wu T; Bound MJ; Zhao BR; Standfield SD; Bellon M; Jones KL; Horowitz M; Rayner CK
    Diabetes Care; 2013 Jul; 36(7):1913-8. PubMed ID: 23359361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.